BACKGROUND: The purpose of this study was to comprehensively and quantitatively summarize the prognostic value of microvessel density (MVD) and lymphatic vessel density (LVD) for the survival of patients with head and neck squamous cell carcinoma (HNSCC). METHODS: Relevant literatures were identified using Medline and EMBASE. A meta-analysis was performed to clarify the prognostic role of MVD and LVD. RESULTS: A total of 18 articles (13 for MVD and 5 for LVD; n = 1279 and n = 408) were pooled for the global meta-analysis. The mortality was 1.23-fold higher for patients whose MVD counts were above the cutoff (risk ratio [RR], 1.23; 95% confidence interval [CI], 0.99-1.52), compared with those below it, and this result was on a borderline (p = .06). The mortality of patients with high LVD counts was 2.07-fold higher (RR, 2.07; 95% CI, 1.16-3.71; p = .01). CONCLUSION: High counts of LVD, not MVD, are associated with worse 5-year overall survival (OS) in patients with HNSCC.
BACKGROUND: The purpose of this study was to comprehensively and quantitatively summarize the prognostic value of microvessel density (MVD) and lymphatic vessel density (LVD) for the survival of patients with head and neck squamous cell carcinoma (HNSCC). METHODS: Relevant literatures were identified using Medline and EMBASE. A meta-analysis was performed to clarify the prognostic role of MVD and LVD. RESULTS: A total of 18 articles (13 for MVD and 5 for LVD; n = 1279 and n = 408) were pooled for the global meta-analysis. The mortality was 1.23-fold higher for patients whose MVD counts were above the cutoff (risk ratio [RR], 1.23; 95% confidence interval [CI], 0.99-1.52), compared with those below it, and this result was on a borderline (p = .06). The mortality of patients with high LVD counts was 2.07-fold higher (RR, 2.07; 95% CI, 1.16-3.71; p = .01). CONCLUSION: High counts of LVD, not MVD, are associated with worse 5-year overall survival (OS) in patients with HNSCC.
Authors: Miriam Gross-Cohen; Sari Feld; Ilana Doweck; Gera Neufeld; Peleg Hasson; Gil Arvatz; Uri Barash; Inna Naroditsky; Neta Ilan; Israel Vlodavsky Journal: Cancer Res Date: 2016-03-24 Impact factor: 12.701
Authors: Joanna A Niemiec; Agnieszka Adamczyk; Aleksandra Ambicka; Anna Mucha-Małecka; Wojciech M Wysocki; Beata Biesaga; Marek Ziobro; Ida Cedrych; Aleksandra Grela-Wojewoda; Małgorzata Domagała-Haduch; Joanna Wysocka; Janusz Ryś; Beata Sas-Korczyńska Journal: Am J Transl Res Date: 2017-03-15 Impact factor: 4.060
Authors: Michael Evans; Harry Michael Baddour; Kelly R Magliocca; Susan Müller; Sreenivas Nannapaneni; Amy Y Chen; Sunjin Kim; Zhengjia Chen; Dong M Shin; Andrew Y Wang; Nabil F Saba; Zhuo G Chen Journal: Cancer Med Date: 2018-12-21 Impact factor: 4.452
Authors: Thomas K Kilvaer; Erna-Elise Paulsen; Sigurd M Hald; Tom Wilsgaard; Roy M Bremnes; Lill-Tove Busund; Tom Donnem Journal: PLoS One Date: 2015-08-25 Impact factor: 3.240
Authors: Tomasz Szafarowski; Janusz Sierdzinski; Miroslaw J Szczepanski; Theresa L Whiteside; Nils Ludwig; Antoni Krzeski Journal: Eur Arch Otorhinolaryngol Date: 2018-05-10 Impact factor: 2.503